Journal of Cancer and Cancer Screening is an online peer-reviewed journal that publishes significant and up-to-date original research papers, also includes Reviews as well as Editorials and Guest editorials on current topics within the fields of experimental and clinical oncology, from bench to bedside.
Journal of Cancer and Cancer Screening seeks manuscripts that include significant advances in cancer research and that offer a translational association from the laboratory to the treatment center to unlock new prospects for awareness, prevention, diagnosis and treatment of cancer.
Specific areas of interest include, but are not limited to: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; and epidemiology, mechanisms of progression of the malignant phenotype and metastatic disease; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; molecular alterations or biomarkers that predict response or resistance to treatment; translational research in targeted therapies; personalized medicine; novel applications of bioinformatics and biostatistics; tumor immunotherapy; large-scale molecular characterization of human tumors and innovative methods with potential applicability to clinical research.
Journal of Cancer and Cancer Screening allows the immediate publication of accepted articles and the presentation of outsized amount of data and additional information to make sure that research is distributed as resourcefully and promptly as possible to the scientific community.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Open Access Publication and Creative Commons Licensing:
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share A like 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Ahead of Print policy:
Articles published online under the Ahead of Print models are considered published and can be cited and quoted using the DOI as the reference source. Acquaint has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
Acute & Chronic Leukemia's
Acute granulocytic leukemia
Advanced metastatic breast cancer
Anti-Cancer Drug Discovery
Autologous stem cell transplant
Cancer Prevention methods
Cancer therapeutics and targets
Cellular and Molecular Biology of Cancer
Cellular Division and Proliferation
Cellular Signal Pathways
Chronic myelogenous leukemia
DNA Repair and Apoptosis
Early Detection and Diagnosis
Hairy cell leukemia symptoms
Head and Neck Cancer
Hereditary prostate cancer genes
In situ non-invasive cancer
Intestinal cancer symptoms
Invasive lobular carcinoma
Large-scale molecular characterization of human tumors
Metastatic ovarian cancer
Microenvironment and immunology
Molecular alterations or biomarkers that predict response
Molecular and cellular pathobiology
Molecular targeted agents and immune therapies
Oat cell cancer symptoms
Oncogenomics, proteomics and metabolomics
Oncology diagnostic tools
Philadelphia chromosome-positive chronic myelogenous leukemia
Pituitary gland cancer
Prevention and cancer epidemiology
Progression of the malignant phenotype
Radiotherapy and biotherapy
Single and combined drug administration modalities
Squamous cell carcinoma
Stem Cell Biology
Therapeutics of the drugs
Tumor and stem cell biology
Tumor immunology and virology